Amendments to Debt Facility with Avenue Capital Group
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Recce Pharmaceuticals Ltd. has announced amendments to its debt facility with Avenue Capital Group, extending the interest-only period to support ongoing clinical trials. In exchange for these amendments, Recce will issue additional warrants to Avenue Capital Group.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Appendix 4E and FY26 Annual Report
- HREC Approves Comparator Study for Pivotal Phase 3 DFI
- Vietnamese Patent Granted for RECCE Anti-Infectives
- AUD $3.7M Income Tax Refund Received
- Placement & SPP to raise $8 million
Later from Recce Pharmaceuticals
All Recce Pharmaceuticals news releasesFollow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals